道通科技(688208.SH)擬變更西安項目實施地點
格隆匯12月9日丨道通科技(688208.SH)公佈,公司第三屆董事會第五次會議、第三屆監事會第五次會議審議通過了《關於變更部分募投項目實施地點的議案》。公司擬變更募集資金投資項目之西安項目的實施地點,原實施地塊公司將交由西安高新區土地儲備中心收儲,並授權公司管理層簽署本次變更實施地點相關的合同及文件。
變更後實施地點位於西安高新區中央創新區,中央創新區為西安高新區的核心區域,目前正在按照國際一流標準建設,以產業科技創新、金融商務為主導,集行政、教育、會展、文化、商業、居住、醫療等功能為一體,區域位置優勢明顯,有利於公司人才引進和長遠發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.